Analysts at Stifel, however, view this storm as nothing but a “massive ... Looking ahead to fiscal 2025, management remains ...

ST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today appointed Jonathan Siegmann as Managing Director of Equity Research, covering the aerospace and defense industry.

Stifel sees Microsoft's stock staying range-bound until Azure growth outpaces rising capex, lowering its price target to $475 ...

Compass Pathways gains Stifel's Buy rating as its COMP360 psilocybin treatment advances in Phase 3 trials. Key depression ...

Stifel lowered the firm’s price target on Microsoft (MSFT) to $475 from $515 and keeps a Buy rating on the shares after having spent time ...

Microsoft shares traded at $379.43 as of 2:12 p.m. GMT-4 on Monday, down $13.88, or 3.5%, from the previous close.

Stifel Financial Corp. announced the appointment of Jonathan Siegmann as Managing Director of Equity Research, focusing on the aerospace and defense sector, effective immediately. Siegmann, who ...

Stifel’s analysis highlights Dianthus Therapeutics ... King as its new Chief Commercial Officer, bringing his extensive experience in biotechnology to bolster Dianthus’s commercial strategy.

Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A. offer trust and related ...

Investment analysts at Stifel Canada issued their Q1 2025 EPS estimates for Savaria in a research note issued on Thursday, March 6th. Stifel Canada analyst J. Keywood forecasts that the company will ...

Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A. offer trust and related ...

Stifel’s analysis highlights Dianthus Therapeutics as a ... The company recently announced the appointment of John C. King as its new Chief Commercial Officer, bringing his extensive experience in ...